Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Feb;21(2):234–237. doi: 10.1111/j.1365-2125.1986.tb05182.x

Bronchodilator activity of a new inhaled beta 2-adrenoceptor agonist, tulobuterol and its protective effect in exercise-induced asthma.

K R Patel
PMCID: PMC1400920  PMID: 3513811

Abstract

In fifteen patients with asthma tulobuterol, a new beta 2-adrenoceptor agonist, given by inhalation in 100 micrograms increments up to a cumulative dose of 600 micrograms produced dose related increases in both the FEV1 and FVC. The bronchodilation was observed within 5 min of the first dose. In a further nine patients tulobuterol 200 micrograms and 400 micrograms aerosol inhibited exercise-induced asthma following 6-8 min treadmill exercise and the effect was comparable to 200 micrograms salbutamol aerosol. Minor muscle tremors were observed in two patients with 400 micrograms of tulobuterol but no significant changes in pulse rate or blood pressure were noted.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S. D., Rozea P. J., Dolton R., Lindsay D. A. Inhaled and oral bronchodilator therapy in exercise induced asthma. Aust N Z J Med. 1975 Dec;5(6):544–550. doi: 10.1111/j.1445-5994.1975.tb03860.x. [DOI] [PubMed] [Google Scholar]
  2. Anderson S. D., Seale J. P., Rozea P., Bandler L., Theobald G., Lindsay D. A. Inhaled and oral salbutamol in exercise-induced asthma. Am Rev Respir Dis. 1976 Sep;114(3):493–500. doi: 10.1164/arrd.1976.114.3.493. [DOI] [PubMed] [Google Scholar]
  3. Francis P. W., Krastins I. R., Levison H. Oral and inhaled salbutamol in the prevention of exercise-induced bronchospasm. Pediatrics. 1980 Jul;66(1):103–108. [PubMed] [Google Scholar]
  4. Hetzel M. R., Batten J. C., Clark T. J. Do sympathomimetic amines prevent exercise-induced asthma by bronchodilatation alone? Br J Dis Chest. 1977 Apr;71(2):109–114. doi: 10.1016/0007-0971(77)90091-2. [DOI] [PubMed] [Google Scholar]
  5. Kubo S., Kasé Y., Miyata T., Kito G., Uesaka I. Pharmacological studies of 1-(o-chlorophenyl)-2-tert.-butylaminoethanol (C-78), a new bonchodilator. Arzneimittelforschung. 1975 Jul;25(7):1028–1037. [PubMed] [Google Scholar]
  6. Kubo S., Uesaka I., Matsubara I., Ishihara T., Kasé Y. Pharmacological studies of o-chloro-alpha-[(tert.-butylamino)methyl]benzylalcohol hydrochloride (C-78), a new bronchodilator. II. Actions on the cardio-vascular system and smooth muscle organs. Arzneimittelforschung. 1977 Jul;27(7):1433–1439. [PMC free article] [PubMed] [Google Scholar]
  7. Maesen F., Smeets J., Polderman J. A comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients suffering from a reversible bronchial obstruction. Arzneimittelforschung. 1983;33(12):1696–1698. [PubMed] [Google Scholar]
  8. Patel K. R. Calcium antagonists in exercise-induced asthma. Br Med J (Clin Res Ed) 1981 Mar 21;282(6268):932–933. doi: 10.1136/bmj.282.6268.932. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES